You are here: Home » Reuters » News
Business Standard

Pfizer says delaying drug price hikes after Trump conversation

Reuters  |  WASHINGTON 

WASHINGTON (Reuters) - Pfizer Inc said on Tuesday it was deferring drug price increases for no more than six months after the company's chief executive officer had an extensive conversation with U.S. President Donald Trump. Pfizer said it would defer price increases that went into effect on July 1 until the end of the year or until the president's drug pricing blueprint goes into effect - whichever is sooner. The company said it would return drug prices to their pre-July 1 levels as soon as technically possible.Trump in a tweet on Tuesday said that Pfizer had agreed to roll back drug price ...

This article is no longer available in our repository.

There could be multiple reasons for this.

First Published: Wed, July 11 2018. 05:31 IST